The main eligibility criteria for weight in the STEP 1, 3, 4, and 5 trials were BMI 30 kg/m 2 or BMI 27 kg/m 2 with at least one weight-related comorbidity (hypertension, dyslipidemia, obstructive sleep apnea, or CVD), while patients in STEP 2 had to have a BMI 27 kg/m 2 and T2D
Signing up with Calla Genics means taking your life back
How much weight do most people regain after stopping semaglutide
Weight loss on Wegovy In the STEP UP trial, participants taking the maximum dose of Wegovy, 7.2mg, (semaglutide) lost an average of 20.7% of their body weight over 72 weeks
Long-term weight management requires balanced nutrition and physical activity rather than relying solely on feeling full
Backed by emerging research